Bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V infusion 400 mg in 16 mL; Zirabev® Page last updated: 30 October 2020 Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 804KB) Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 43KB)